Dauntless Investment Group’s Armata Pharmaceuticals ARMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$33.4K Sell
9,105
-194,786
-96% -$929K 0.03% 45
2026
Q2
$1.32M Buy
203,891
+113,311
+125% +$1.04M 1.04% 18
2026
Q1
$928K Buy
90,580
+84,449
+1,377% +$711K 0.61% 22
2025
Q4
$38.5K Buy
+6,131
New +$33.6K 0.03% 55

Other funds holding ARMP

Dauntless Investment Group's ARMP Position: Q3 2026 in Review

Dauntless Investment Group reduced its Armata Pharmaceuticals (ARMP) stake by 96% in Q3 2026, selling an estimated $929K and leaving 9,105 shares worth $33.4K. The position accounts for 0.03% of the portfolio, ranked #45.

Dauntless Investment Group first reported a position in ARMP in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.32M in Q2 2026. 64 funds tracked by Wall St. Rank hold ARMP as of Q3 2026.

  • Dauntless Investment Group held 9,105 shares of Armata Pharmaceuticals worth $33.4K as of Q3 2026.
  • Dauntless Investment Group sold 194,786 Armata Pharmaceuticals shares in Q3 2026, an estimated $929K.
  • Armata Pharmaceuticals made up 0.03% of Dauntless Investment Group's portfolio in Q3 2026, its #45 holding.
  • Dauntless Investment Group first reported a position in Armata Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • Dauntless Investment Group's Armata Pharmaceuticals position peaked at $1.32M in Q2 2026.
  • 64 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q3 2026.

Based on Dauntless Investment Group's 13F filing for Q3 2026, filed 16 Nov 2026.